Document Detail

Toxic Epidermal Necrolysis: Performance of SCORTEN and the Score-Based Comparison of the Efficacy of Corticosteroid Therapy and Intravenous Immunoglobulin Combined Therapy in China.
MedLine Citation:
PMID:  22955159     Owner:  NLM     Status:  Publisher    
Toxic epidermal necrolysis (TEN) represents the most severe drug-related skin condition that is potentially life-threatening with no well-established treatments. The application of corticosteroid therapy is controversial, whereas recently intravenous immunoglobulin (IVIG) therapy is emerging as a promising new method. A severity-of-illness score for TEN (SCORTEN) has gained acceptance in some western countries. In this study, the authors' objectives were to assess the applicability of SCORTEN in Chinese patients with TEN and to evaluate the efficacy of the combination therapy of IVIG and corticosteroid in these patients. The authors performed a retrospective review of data from 61 patients with TEN treated at their intensive care unit from 2000 to 2010 to assess the performance of SCORTEN. In particular, 55 patients between 2002 and 2010 were grouped as a series to compare the therapeutic effects of corticosteroid therapy and IVIG combined therapy contemporaneously. During this period, 16 patients were administered with corticosteroid therapy and 39 were treated with the combination therapy. An initial dose of 1.5 mg/kg/day of methylprednisolone was given to all TEN patients. The combination therapy was combined with a total dose of 2 g/kg IVIG within 5 days. Areas under receiver operating characteristic curves and Hosmer-Lemeshow statistic were analyzed to illustrate the performance of SCORTEN. The comparison of the efficacy of the two therapies was conducted on the basis of clinical outcomes, standardized mortality ratio (SMR), and survival analysis. The overall actual mortality of patients between 2000 and 2010 was 16% (10/61), statistically insignificantly lower than predicted (24%, SMR = 67.98). Excellent discriminatory power (the areas under the receiver operating characteristic curves: 88.9, 88.2, 90.6%) and good calibration (P = .637, .833, .530) were found in all the groups. In patients admitted between 2002 and 2010, IVIG combined therapy showed a trend toward reducing the mortality rate (13%, SMR = 52.35), whereas corticosteroid monotherapy suggested no such difference (31%, SMR = 123.92). Besides, the cumulative survival rates of the combination therapy were higher at almost all the levels of SCORTEN, especially at the score of 5 (P = .039). Compared with corticosteroid alone, the combination therapy arrested progression earlier (P = .013), although it did not significantly lead to a tapering of corticosteroid or a reduction of the time of hospitalization. SCORTEN was generally applicable to Chinese patients with TEN. The comparison of the effect indicated that the combination therapy might achieve a better therapeutic effect than the administration of corticosteroid alone, especially in severe TEN patients.
Qin-Yuan Zhu; Li Ma; Xiao-Qun Luo; Hui-Yuan Huang
Related Documents :
3874009 - Improved graft patency in patients treated with platelet-inhibiting therapy after coron...
19506489 - Campfire burns of the palms in crawling infants in saudi arabia: results following rele...
8795509 - Results of a prospective, randomized trial of surgery versus thrombolysis for occluded ...
17275089 - Bacterial keratitis after penetrating keratoplasty: incidence, microbiological profile,...
23023529 - Retina rejuvenation therapy for diabetic macular edema: a pilot study.
16368419 - Wrapping of the left internal thoracic artery with an expanded polytetrafluoroethylene ...
8894569 - Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or ...
17429559 - A prospective, randomized controlled trial of the use of an anal purse-string suture to...
18541929 - Biofeedback with and without surgery for fecal incontinence improves maximum squeeze pr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-5
Journal Detail:
Title:  Journal of burn care & research : official publication of the American Burn Association     Volume:  -     ISSN:  1559-0488     ISO Abbreviation:  J Burn Care Res     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101262774     Medline TA:  J Burn Care Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
From the Department of Dermatology, Huashan Hospital, Fudan University, Peoples Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evidence of a Role for Fibrocyte and Keratinocyte-Like Cells in the Formation of Hypertrophic Scars.
Next Document:  The Impact of Recent Changes in Smoke Alarm Legislation on Residential Fire Injuries and Smoke Alarm...